(Q37503380)

20 August 2017

1 reference

title

Current and future treatments of autoimmune hepatitis (English)

1 reference

20 August 2017

Albert J Czaja

1

1 reference

20 August 2017

1 June 2009

1 reference

Expert Review of Gastroenterology & Hepatology

20 August 2017

1 reference

20 August 2017

3

1 reference

20 August 2017

3

1 reference

20 August 2017

269-291

1 reference

Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

20 August 2017

1 reference

Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study.

21 January 2018

1 reference

Favorable outcomes of autoimmune hepatitis in a community clinic setting

21 January 2018

1 reference

Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.

21 January 2018

1 reference

Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitis

21 January 2018

1 reference

Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy

21 January 2018

1 reference

Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis

21 January 2018

1 reference

Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis

21 January 2018

1 reference

Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis

21 January 2018

1 reference

Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal

21 January 2018

1 reference

Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis

21 January 2018

1 reference

Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening.

21 January 2018

1 reference

Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance

21 January 2018

1 reference

Evolving new therapies of autoimmune hepatitis

21 January 2018

1 reference

Emerging Treatments for Autoimmune Hepatitis

21 January 2018

1 reference

Treatment challenges and investigational opportunities in autoimmune hepatitis

21 January 2018

1 reference

Frequency of antibody to hepatitis C virus in asymptomatic HBsAg-negative chronic active hepatitis

21 January 2018

1 reference

Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis

21 January 2018

1 reference

Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.

21 January 2018

1 reference

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

21 January 2018

1 reference

Diagnosis and treatment of autoimmune hepatitis

21 January 2018

1 reference

Treatment strategies in autoimmune hepatitis

21 January 2018

1 reference

Current therapy for autoimmune hepatitis

21 January 2018

1 reference

Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience

21 January 2018

1 reference

Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors

21 January 2018

1 reference

The clinical pharmacology of 6-mercaptopurine

21 January 2018

1 reference

Selective inhibition of inflammatory gene expression in activated T lymphocytes: a mechanism of immune suppression by thiopurines

21 January 2018

1 reference

Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implications

21 January 2018

1 reference

Corticosteroid Pharmacokinetics in Liver Disease

21 January 2018

1 reference

Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms

21 January 2018

1 reference

Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance

21 January 2018

1 reference

Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine

21 January 2018

1 reference

Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease

21 January 2018

1 reference

Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease

21 January 2018

1 reference

Evaluation and management of osteoporosis in liver disease

21 January 2018

1 reference

Liver disease and osteoporosis.

21 January 2018

1 reference

Bone disorders in chronic liver disease

21 January 2018

1 reference

Primary prophylaxis of esophageal variceal bleeding in cirrhosis.

21 January 2018

1 reference

Immune phenotype of chronic liver disease.

21 January 2018

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

Diagnosis and Treatment of Hepatocellular Carcinoma

21 January 2018

1 reference

Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis

21 January 2018

1 reference

Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy

21 January 2018

1 reference

Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis

21 January 2018

1 reference

Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis

21 January 2018

1 reference

Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis

21 January 2018

1 reference

Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy

21 January 2018

1 reference

Effects of serum aspartate aminotransferase levels in patients with autoimmune hepatitis influence disease course and outcome

21 January 2018

1 reference

Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease

21 January 2018

1 reference

Diagnosis and treatment of autoimmune hepatitis at age 65 and older

21 January 2018

1 reference

Clinical features of type 1 autoimmune hepatitis in elderly Italian patients

21 January 2018

1 reference

Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly

21 January 2018

1 reference

Management and outcome of pregnancy in autoimmune hepatitis

21 January 2018

1 reference

Autoimmune hepatitis and pregnancy: a rheumatologist's dilemma

21 January 2018

1 reference

Pregnancy in autoimmune hepatitis: outcome and risk factors.

21 January 2018

1 reference

Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding?

21 January 2018

1 reference

Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites.

21 January 2018

1 reference

Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery.

21 January 2018

1 reference

A gender gap in autoimmunity.

21 January 2018

1 reference

Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics

21 January 2018

1 reference

Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis

21 January 2018

1 reference

Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases.

21 January 2018

1 reference

Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.

21 January 2018

1 reference

Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience

21 January 2018

1 reference

Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis.

21 January 2018

1 reference

Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis

21 January 2018

1 reference

Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis

21 January 2018

1 reference

Long-term prognosis in patients with severe late radiation enteropathy: a prospective cohort study

21 January 2018

1 reference

The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine

21 January 2018

1 reference

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.

21 January 2018

1 reference

Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus

21 January 2018

1 reference

Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.

21 January 2018

1 reference

A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis

21 January 2018

1 reference

Mycophenolate mofetil as second line therapy in autoimmune hepatitis?

21 January 2018

1 reference

Cost-effectiveness of pharmacotherapy for autoimmune hepatitis

21 January 2018

1 reference

Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis

21 January 2018

1 reference

Budesonide in previously untreated autoimmune hepatitis.

21 January 2018

1 reference

Rapamycin successfully treats post-transplant autoimmune hepatitis

21 January 2018

1 reference

Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature

21 January 2018

1 reference

Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine

21 January 2018

1 reference

On the limitation of 6-tioguaninenucleotide monitoring during tioguanine treatment

21 January 2018

1 reference

Transplantation for autoimmune hepatitis

21 January 2018

1 reference

Long-term outcome of liver transplantation for autoimmune hepatitis

21 January 2018

1 reference

Liver transplantation for autoimmune hepatitis: a single-center experience.

21 January 2018

1 reference

Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal

21 January 2018

1 reference

Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome.

21 January 2018

1 reference

Recurrence of autoimmune hepatitis after liver transplantation

21 January 2018

1 reference

Recurrent autoimmune hepatitis after orthotopic liver transplantation

21 January 2018

1 reference

Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis.

21 January 2018

1 reference

De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation

21 January 2018

1 reference

Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults.

21 January 2018

1 reference

A cause of late graft dysfunction after liver transplantation in children: de-novo autoimmune hepatitis

21 January 2018

1 reference

Post-liver transplantation de novo hepatitis with overlap features

21 January 2018

1 reference

Diagnostic issues in liver transplantation pathology

21 January 2018

1 reference

Liver biopsy interpretation for causes of late liver allograft dysfunction

21 January 2018

1 reference

Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus.

21 January 2018

1 reference

Plasma cell hepatitis in liver allografts: Variant of rejection or autoimmune hepatitis?

21 January 2018

1 reference

The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers

21 January 2018

1 reference

Allograft rejection after liver transplantation for autoimmune liver diseases

21 January 2018

1 reference

Autoimmune hepatitis. Part A: pathogenesis

21 January 2018

1 reference

A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens

21 January 2018

1 reference

Animal models for autoimmune hepatitis.

21 January 2018

1 reference

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection

21 January 2018

1 reference

Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells

21 January 2018

1 reference

Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis

21 January 2018

1 reference

Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.

21 January 2018

1 reference

Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders

21 January 2018

1 reference

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group

21 January 2018

1 reference

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

21 January 2018

1 reference

A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis

21 January 2018

1 reference

A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis

21 January 2018

1 reference

Serious liver disease induced by infliximab

21 January 2018

1 reference

Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis

21 January 2018

1 reference

21 January 2018

1 reference

Hepatic diseases--hitting the target with inhibitory RNAs

21 January 2018

1 reference

Unlocking the potential of the human genome with RNA interference

21 January 2018

1 reference

Inhibition of hepatitis B virus in mice by RNA interference

21 January 2018

1 reference

Synthetic amino acid copolymers that bind to HLA-DR proteins and inhibit type II collagen-reactive T cell clones

21 January 2018

1 reference

Oral tolerance in the treatment of inflammatory autoimmune diseases

21 January 2018

1 reference

Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression.

21 January 2018

1 reference

Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease

21 January 2018

1 reference

T regulatory cells and autoimmune liver disease

21 January 2018

1 reference

The new immunology--the end of immunosuppressive drug therapy?

21 January 2018

1 reference

Transplantation of anergic histoincompatible bone marrow allografts

21 January 2018

1 reference

Autoimmune hepatitis in the elderly

21 January 2018

1 reference

Recurrence of autoimmune hepatitis after liver transplantation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.09.15

1 reference

20 August 2017

1 reference

PubMed ID

19485809